Auxesis Pharma strengthens its Board with three new members

At the Annual General Meeting of AUXESIS PHARMA HOLDING AB (publ), held on June 12, 2026, it was resolved to elect two new members to the Board of Directors. The newly elected members are Anna Tenstam and Lars-Olof Peterson. Roar Adelsten was elected Chairman of the Board.

The appointments strengthen the Board's combined expertise and experience as the Company continues its strategic development. The newly elected members bring valuable experience in business development, leadership, strategy, and corporate growth.

The strengthened Board is expected to enhance AUXESIS PHARMA HOLDING AB's ability to achieve its long-term objectives and continue advancing its pharmaceutical technology platform.

We look forward to contributing to the Company's continued development and creating long-term value for shareholders, partners, and other stakeholders. AUXESIS PHARMA HOLDING operates in a field with significant opportunities, and we look forward to supporting the Company's next phase of growth.

Roar Adelsten, Chairman of the Board

Resolutions adopted at the Annual General Meeting

The Annual General Meeting also resolved to adopt the income statement and balance sheet and to discharge the Board of Directors and the Chief Executive Officer from liability for the previous financial year.

The new Board assumes office immediately following the conclusion of the Annual General Meeting.